NM_015166.4:c.65G>A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_015166.4(MLC1):​c.65G>A​(p.Arg22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,613,626 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R22W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

MLC1
NM_015166.4 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 3.12

Publications

13 publications found
Variant links:
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0071160197).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLC1NM_015166.4 linkc.65G>A p.Arg22Gln missense_variant Exon 2 of 12 ENST00000311597.10 NP_055981.1 Q15049-1A0A024R4V4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLC1ENST00000311597.10 linkc.65G>A p.Arg22Gln missense_variant Exon 2 of 12 1 NM_015166.4 ENSP00000310375.6 Q15049-1
MLC1ENST00000395876.6 linkc.65G>A p.Arg22Gln missense_variant Exon 2 of 12 1 ENSP00000379216.2 Q15049-1
MLC1ENST00000442311.1 linkc.65G>A p.Arg22Gln missense_variant Exon 2 of 8 5 ENSP00000401385.1 A6PVC3

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152216
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000471
AC:
118
AN:
250418
AF XY:
0.000435
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00436
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000441
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000163
AC:
238
AN:
1461292
Hom.:
1
Cov.:
32
AF XY:
0.000184
AC XY:
134
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.00259
AC:
103
AN:
39700
South Asian (SAS)
AF:
0.00119
AC:
103
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52894
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5722
European-Non Finnish (NFE)
AF:
0.0000162
AC:
18
AN:
1112006
Other (OTH)
AF:
0.000199
AC:
12
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152334
Hom.:
0
Cov.:
33
AF XY:
0.000201
AC XY:
15
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41572
American (AMR)
AF:
0.0000653
AC:
1
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5182
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.000276
ExAC
AF:
0.000552
AC:
67
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Megalencephalic leukoencephalopathy with subcortical cysts 1 Uncertain:3
-
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

Jun 29, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not provided Uncertain:2
Jul 12, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 22 of the MLC1 protein (p.Arg22Gln). This variant is present in population databases (rs184241759, gnomAD 0.5%). This missense change has been observed in individual(s) with megalencephalic leukoencephalopathy with subcortical cysts (PMID: 21160490). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 225412). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects MLC1 function (PMID: 22416245). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Feb 10, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The R22Q variant in the MLC1 gene has been reported previously in a patient with megalencephalic leukoencephalopathy with subcortical cysts, however, this patient was not found to have a pathogenic variant on the other MLC1 allele (Wang et al., 2011). The R22Q variant is observed in 43/8556 (0.5%) alleles from individuals of East Asian background, in the ExAC dataset (Lek et al., 2016). The R22Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals. While transfection studies indicate that the R22Q variant affected intracellular protein localization, protein/mRNA expression levels for R22Q were comparable with wild type (Xie et al., 2012). Therefore, we interpret R22Q as a variant of uncertain significance. -

not specified Uncertain:1
Sep 14, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MLC1 c.65G>A (p.Arg22Gln) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00047 in 250418 control chromosomes (gnomAD), predominantly at a frequency of 0.0044 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in MLC1 causing Megalencephalic Leukoencephalopathy With Subcortical Cysts 1 (0.0011), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.65G>A has been reported in the literature in individuals affected with Megalencephalic Leukoencephalopathy With Subcortical Cysts 1, including one sibling pair that carried a second pathogenic variant in trans (Wang_2011). The variant was also found in one affected individual with a benign variant on the second allele (Wang_2011) and in one individual that carried a likely pathogenic variant in cis and another potentially pathogenic variant (c.772-1G>C) in trans (Cao_2016). These data indicate that the variant may be associated with disease. One functional study demonstrated that the variant protein is mislocalized in the cell, with 8.26% of the protein being trafficked to the cell surface, and the remainder being trapped in the endoplasmic reticulum (Xie_2012). Five ClinVar submitters have assessed the variant since 2014: four classified the variant as of uncertain significance, and one as likely pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Megalencephalic leukoencephalopathy with subcortical cysts Uncertain:1
Jan 06, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.062
T
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;T;.
Eigen
Benign
-0.0059
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.92
.;D;D
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.0071
T;T;T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Benign
1.4
L;L;.
PhyloP100
3.1
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-3.4
D;D;D
REVEL
Uncertain
0.44
Sift
Uncertain
0.0070
D;D;D
Sift4G
Uncertain
0.021
D;D;D
Polyphen
0.22
B;B;.
Vest4
0.73
MVP
0.88
MPC
0.29
ClinPred
0.16
T
GERP RS
5.5
Varity_R
0.34
gMVP
0.41
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184241759; hg19: chr22-50523267; API